Call for Tender “Antisuperbugs”
The deadline for submission of proposals will be on the 28th of October 2019.
The deadline for submission of proposals will be on the 28th of October 2019.
Myelo Therapeutics GmbH announced today that the European Medicines Agency (EMA) has granted an Orphan Drug Designation to its orally applied new chemical entity Myelo001 (Imidazolyl ethanamide pentandioic acid) for the treatment of Acute Radiation…
The Open Call for European Business Networks (EBNs) is launched on the 22nd of July and it will be open until the 3rd of November 2019, 17:00h Brussels time.
BioRiver Boost! 2019 - the competition for Life Science founders for best business contacts / applications until 31st August 2019 / Finalists profit from direct contacts to market leaders and decision-makers
German Research Minister Anja Karliczek and Governing Mayor of Berlin Michael Müller signed an administrative agreement between the federal government and the state of Berlin that lays out the details for the integration of the Berlin Institute of…
The H2020-INNOSUP-1 project C-Voucher, will publish on 1st Augusta call to select 18 European SMEs (Adopters) willing to approach the circular economy business and create circular feasibility plans for their companies. The call will remain open…
MDC researcher Dr. Stephan Preibisch and a team of scientists from Berlin, Bochum, and Düsseldorf have won the first round of the Federal Ministry of Education and Research’s “In Vitro Challenge.” The goal of the competition is to find clever…
Expensive equipment, poor use of capacity: a problem familiar to many healthcare providers. After all, large medical technology devices for MRIs and CTs are costly both to acquire and to maintain. Berlin based company Medneo has been offering a…
Healthcare is one of the most exciting sectors that is expected to fully embrace the development of 3-D printing. Patients and providers alike are looking to a future where the custom fabrication of prostheses, implants, and most likely even whole…
Company will use funds to scale its Cara Care digital therapeutic for life-interrupting digestive diseases.